Active Pharmaceutical Ingredient

Denosumab API Manufacturer & Supplier in India

Also known as: Prolia / Xgeva

CAS: 615258-40-7 Bone Health / Oncology USP / BP / IP / EP Bulk Supply Available
Denosumab API Manufacturer India | Mediocon Inc
Denosumab — Pharmaceutical Grade API

Product Overview

CAS No: 615258-40-7  |  MF: Monoclonal Antibody  |  MW: ~147 kDa

Denosumab is a fully human monoclonal antibody (IgG2) that targets RANKL (receptor activator of nuclear factor kappa-B ligand), inhibiting osteoclast formation and function to reduce bone resorption. It is used for osteoporosis, bone metastases, and giant cell tumor of bone. Mediocon Inc supplies pharmaceutical-grade Denosumab for bulk pharma manufacturing.

Key Features

  • Analgesic, antipyretic & anti-inflammatory
  • USP/BP/IP compliant quality
  • Widely used in cardiovascular therapy
  • Suitable for tablet and effervescent formulations

Applications

  • Postmenopausal osteoporosis
  • Bone metastases in solid tumors
  • Giant cell tumor of bone
  • Cancer treatment-induced bone loss

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameDenosumab
Also Known AsProlia / Xgeva
CAS Number615258-40-7
Molecular FormulaMonoclonal Antibody
Molecular Weight~147 kDa
CategoryAnti-RANKL Monoclonal Antibody / Bone Resorption Inhibitor
AppearanceClear to Opalescent Liquid or Lyophilized
GradeUSP / BP / IP / EP

Analytical Specifications

ParameterSpecification
Assay99.0% Min.
Loss on DryingNMT 1.0%
Melting PointN/A (biologic)
Heavy MetalsComplies
pHN/A
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Denosumab (CAS 615258-40-7) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Denosumab is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Denosumab API

What is the minimum order quantity for Denosumab API?
Mediocon Inc supplies Denosumab with a minimum order quantity of 1 kg (sample packs available for R&D). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Denosumab does Mediocon supply?
We supply Denosumab conforming to USP / BP / IP / EP pharmacopoeial standards. Each batch is tested against full pharmacopoeial specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Denosumab API?
Every shipment of Denosumab comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Denosumab bulk orders?
Standard lead time for Denosumab is 2–4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging (25 kg HDPE drums / aluminium foil bags). All shipments include temperature-controlled logistics options where required by the product's storage conditions.
💬
Mediocon AI
Hello 👋 How can I help you today?